ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TYR Tyratech (DI/S)

2.95
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tyratech (DI/S) LSE:TYR London Ordinary Share COM SHS USD0.001 (DI / REGS)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.95 2.70 3.20 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Tyratech Share Discussion Threads

Showing 1401 to 1424 of 2550 messages
Chat Pages: Latest  66  65  64  63  62  61  60  59  58  57  56  55  Older
DateSubjectAuthorDiscuss
11/7/2013
00:39
Not bitter at all. I always spend time fully researching any potential investment.
They have been in the commercialisation stage before and they have failed, what's the difference this time around?
It's only the company telling us that their products are better. I'm sure if you asked Raid they would say their fly killer was best.
If VaMOUSSE is so great why is there no retailer interest?
They said it would be launch in 1st quarter of 2013 through major pharmacies under their own brands. Now Q3 and still no sign. There are other non toxic alternatives out there already.

Terminix bailed out of the first deal and are now just paid for the use of their name. Tyratech manufacture and distribute the product themselves now.

cliley454
10/7/2013
16:57
cliley,
I have to agree with zelder.
Of course the products work, if you actually read the links that you have posted you can see that Terminex just re-negotiated the agreement with Tyratech. If Terminex thought that the products were no good, why would they enter into the second and current agreement?
The head lice product alone is worth the mkt cap of Tyratech.
When my kids had headlice years ago, I would have paid any amount to get the Tyratech product.

dassaco
10/7/2013
13:27
'They've done it all once before and failed. The products are no good imho.'

You sound very bitter towards TyraTech, reading your last post and the other one from December. I have no idea why, maybe you made a big loss? That would explain a lot, especially looking at the amount of time you spent digging out years old articles!

Today's company is completely different and Tyratech is now in the commercialisation stage for many of their products, nearly all of which have produced as good, if not better results than the leading synthetic competitors. Not sure how you can say they are no good!
The head lice product (VaMOUSSE) is sure to be a winner and has the potential to be massive. Exciting times are a 'head'!

zelder
10/7/2013
10:45
You guys need to dig a little deeper. They have been through all a this before with a previous group of PI's, all who lost their shirts.

Insect spray product launch 2012


Actually launched 5 years earlier in 2007 and failed.


They've done it all once before and failed. The products are no good imho.

Agreement with Terminix 2008


Terminix dump Tyratech 2012


Then back with a better deal for Terminix


From 2006
"SYNGENTA TO LICENSE INSECTICIDE TECHNOLOGY
Syngenta Professional Products has signed a licensing agreement with the XL TechGroup (www.xltg.com) which grants Syngenta rights to natural technologies developed by TyraTech. These should allow Syngenta to rapidly develop formulations targeted at specific insecticide applications. The core technology, which uses the successful reproduction of chemo receptors in a stable cell line to identify highly effective essential oil compounds, has a wide variety of applications. TyraTech has already created an entirely new class of natural insecticides that have been shown to be highly effective in independent trials. The ingredients are based on natural plant oils, which are environmentally-friendly and designed to be harmless to humans, animals and the environment. Under the proposed terms of the agreement, TyraTech will receive upfront and milestone payments, followed by royalties based on product sale revenues"
www.crop-protection-monthly.co.uk/Archives/CPMJuly2006.doc
FAILED!

Sound familiar?

Again in 2009.

What happened to these agreement?



3 years on and 2012
"TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, is pleased to announce that the Company has entered into a License Agreement and Joint Venture Agreement (together the "Agreements") with Amvac Chemical Corporation ("AMVAC"), a wholly-owned subsidiary of American Vanguard Corporation (NYSE:AVD). The Agreements create a joint venture (the "Joint Venture") to develop and commercialise existing and new pesticide products featuring TyraTech's Nature's Technology(TM), which harnesses the synergy of natural ingredients to deliver products with market leading levels of efficacy and safety."


Product launch


Product launch


Product launch


Product launch


Product launch


Where are these products now?

It's all been done before!

DYOR

cliley454
05/7/2013
18:48
.....Analysts that follow American Vanguard approved the tie-up, with one writing that "Given the outright hatred that many people have towards Monsanto ...and other major insecticide and herbicide manufacturers, not to mention the toxicity of many conventional pesticides and herbicides, there's a chance that these products could really fill a niche". The analyst pointed out this niche could be worth upwards of US$4 billion.'
zelder
05/7/2013
18:47
An online article(4th July)about TyraTech: www.oilbarrel.com
zelder
02/7/2013
21:22
You couldn't be more wrong, imo.
zelder
02/7/2013
17:05
Dead donkey this one.
jxman
30/6/2013
23:02
With the amount of times the words exciting/excited were used, i think it's pretty safe to assume they think exciting times are ahead!
zelder
30/6/2013
10:58
Well done zelder - that might coincide with the increase in volume over the past few months then
techair
30/6/2013
09:54
Great find, Zelder.
It looks like things are happening fast.

dassaco
29/6/2013
23:41
Not sure if this has been mentioned before (don't think so) but i stumbled across the transcript of American Vanguard Corporations first quarter 2013 conference call(May).

TyraTech was the topic of several conversations and reading what was said shows just how excited they are with TyraTech and it's products.


hxxp://www.american-vanguard.com/LinkClick.aspx?fileticket=0abaqwQTohs%3D&tabid=61

Have copied and pasted a few of the discussions about TyraTech:


Eric G. Wintemute, Chairman, President and Chief Executive Officer:

Lastly, let me comment about our exciting investment in TyraTech. In November last year we partnered to form new enterprise advance to focus on delivering safe and efficacious insecticides across the specialty and crop markets.
Initial product lines at the retail market throughout the United States in January this year under the Terminix brand. We expect to reach wider penetration of this market in the balance of this year, resulting in more significant sales over the coming years.

We are also looking to add additional products to the line and are selecting our retail partners on a global basis. So what's different about these EPA exempt naturally occurring insecticides? It's the motive action. Most of our insecticide in AMVAC works as a choline esterase inhibitor by blocking the synapse, the insecticide causes a system wide shut down to the target pest.
The minute levels needed to be efficacious on invertebrates do not have a toxic insect on vertebrates. But both invertebrates and vertebrates are susceptible to common [indiscernible]inhibitors. TyraTech's technology blocks the tyramine receptors and causes the same systems wide shift them to the target path. Difference is tyramine receptors are unique to invertebrates and are not present in vertebrates. This makes the technology uniquely safe for household use.

We see multiple opportunities to build on this platform, both as standalone and as a partner with existing chemistry. TyraTech also has excellent opportunities in animal health and personal care.

Due to these factors we made a strategic investment to acquire about 30% ownership of TyraTech.



Q:

I'm sorry, did you guys, you mentioned something about Terminix. Could you
just elaborate on that, is that some thing to closer renew, I don't remember that one before?

A:

It is. So, what TryaTech has is a license use that the Terminix name and has created a brand which is – we're now have at least under our new enterprise TryaTech called Amvac. So that the product that would see on the shelf will say Terminix, flying insect – taking insect and there is crawling insect. So, those three brands are out there today. And so we're excited about it. This is the first time Terminix in its 100 plus years has put his name on a product and these are products that work extremely well, I think the number what might be considered kind of natural chemicals ones that not performed well, but I can tell you this product performance is well as the products that we have seen historically that are synthetic chemistry.

So we're very excited about it. We think we're getting lot of excitements from other retail outlets and as I mentioned we expect a number of new retail outlets to be signed up over the balance of this year or we learning to be a – what we hope to be a very strong 2014.

That's in United States side. And as I said, international we're now looking to takes these products from registrations at ETA, other countries do require registration for these in their regulatory bodies,but we do have registrations in a variety of countries that have come through and we are looking to position those products line.


Q:

Okay. I have also just a follow-up on the Terminix brand. I assume you –
what you're saying is that the naturally current TyraTech technology towards being used for the – I assume that's part of the – and promoting that brand, leveraging that selling angle. I'm just wondering if you have – just sort of what the market opportunity is for those – I guess the household insecticides that you're targeting and where has the success been so far, like, which big
box retailers or do you have shelf space at and how do you see that playing out going forward like increasing shelf space with whatever big boxes you're with now, or broadening to multiple big box retailer? Just on – I want to understand some parameters and how that – how are going to promote that growth of that product going forward?

A:

Right. So the Terminix brand is on a license and is – and they have – because I'm sorry, as you bring up to utilize their name with that I think the advantage is the Terminix's name is synonymous with efficacy as the strongest pest control brand in the United States. And so by taking what is called very safe product line, but now marrying that with a brand that says, hey, we were.
That's where we're seeing all the excitement.
So getting people to try the product, because once people try it they will be sold for life. So that's kind of bad aspect of it. And I'm just trying to remember what your...

Q:

Well, just putting two parameters around the market opportunity, how big is
that? Well, is that household insecticide category? And where – which retailers have you have success with thus far?

A:

Right, right. So the initial launch is with Home Depot. And so we've been somewhere between 1,500 and 18 a day – net 1,800 stores I think nationally and I think we're somewhere in that 1,500 range. And so that's – if you went out to your Home Depot you will see there and I encourage each of you on the call to go make a purchase for $5 and bring it home. I think you'll be enthused.
Other retailers, we're talking to each of the other retailers at this point and expect – we've got a couple that has – have already signed up for use in third quarter and fourth quarter. But so far nobody had said that they don't – they wouldn't be really highly interest in this market.
So we think we're going to have great penetration there. The global market – I know the Chairman of TyraTech had put something out that say that, globally this is a $5 billion market opportunity as far as that's the market that we'll participating in. I make that statement without having done that then else myself but I know it's a significant market. And as would look branch from this home based market to the lawn and garden market I mentioned, we are excited about taking this technology into cost as and then taking a look at this technology with other chemistries -- current existing chemistries that we think that we have, that we could marry together, that might create even a more efficacious product.

Q :

Okay. Thank you very much. The 5 billion that includes home, and lawn and
garden, that's it for home use?

A:

I'm not sure, I don't know.


:

Okay. Fair enough. Thank you.


Q:

Sure. I've got several questions on the Terminix business. I presume the equity
and losses of the joint venture of 96,000 is all of that Terminix business. What kind of revenues do you need to really start to generate something significant for the company?

A:

Well I think we have – I think kind of build this model out that shows somewhere in that 4 million to 5 million breakeven, so that's a target that we're achieving for this year kind of this initial launch here.
Once we got that it's not like we have a whole much more infrastructure to build, to move the needle forward. So I would hope that next year we would see some significant contribution through our overall bottom line but we got as I said there are so many opportunities we are just trying to focus and say okay, what do we do first, and how do we penetrate to do it properly in each of the
market since these products are there, there is a buzz with the Terminix brand. I think we want to push that as hard as what can as quickly as possible.

Q:

What kind of gross margins are there in this business? Are we spotting
something comparable to 50%, very close to what the company does as whole?

A:

Initially, as we kind of break in, you can imagine not being a brand new product line, we are not commanding quite as much market powers we're starting off. So they're down in the 30 to 35% range to start with. But as we move forward, we think we can over time move those into more profitable levels. Certainly we've seen with our past strips, very healthy margins. So in those, the market will yield and specialty markets higher than in crop markets. So overtime we think we'll -- as we gain acceptance of who we are and what we're doing, we'll be able to gain some market power and increase prices there.

zelder
28/6/2013
09:56
I agree Bruno Jactel is an excellent person to have with his sucessful track record.
Things I have noticed in the accounts are:

Amvac now owns 29.4% of TyraTech......they could increase their stake.

Collaborative revenue increased to $3.2 million.
The joint venture with AMVAC was formed to create a new entity, Envance Technologies. A substantial upfront licensing fee was paid as well as annual residual payments to be paid.

The Company may seek to obtain value from some areas of application of its technology in order to reinvest in others.

Possible revenue this year therefore from:
Annual residual payments from Envance Technologies
Some areas of TyraTechs applications may be sold off or licensed annually to other companies.

Also:
Terminix-branded insecticide products already being sold in US through Home Depot and now Target stores as well.
8 products ready for commercialization.
7 more products at various stages of development.

Chairman Alan Reade states in his comments that he is "pleased to say that the Board and all the members of staff are confident and excited about the future of the Company"

With Bruno Jactel, Eric Wintemute (Chairman and CEO of American Vanguard Corporation) and Alan Reade, we now have 3 top executives to get real value from TyraTech's market leading products.

dassaco
27/6/2013
22:25
I'm sure that is only one of many good things going on which we are unaware of!

From what i have read about him, and looking at his excellent record, Bruno Jactel seems the ideal person to make Tyratech extremely successful.

zelder
27/6/2013
17:09
This seems to have been overlooked - didn't know they were in Target stores?

Envance Technologies, LLC has commenced sales of the Terminix-branded insecticide products nationally through The Home Depot and has also initiated test marketing at 100 of the Target Corporation's stores.

techair
27/6/2013
12:12
Only top and bottom line matter.
p1nkfish
27/6/2013
12:04
'Tyratech's new ranges seeing lots of interest':

www.proactiveinvestors.co.uk/companies/news/58438

zelder
27/6/2013
08:46
Yes it does seem to be dragging on.
encarter
27/6/2013
08:16
price action in the next 3 months will be of interest to watch.
market is not patient.

p1nkfish
27/6/2013
07:47
Final Results:
zelder
24/6/2013
21:49
This one is quite good too

hxxp://terminixproducts.com/products/

techair
24/6/2013
10:04
A rather crude if effective youtube video of terminix in action.
mdchand
24/6/2013
09:45
Very interested to see Eric Wintemute (CEO of AVC) join the board - even as a non exec. Hopefully it shows a commitment to Tyratech and the JV to move matters forward.
mdchand
24/6/2013
09:42
Furthermore, following the investment in the Company from American Vanguard Corporation ("AVD") in April 2013, the Company is pleased to announce that Mr. Eric Wintemute has been appointed to the board of the Company as a Non-Executive Director with immediate effect.

Mr. Wintemute is the Chairman and Chief Executive Officer of AVD. Mr. Wintemute joined AVD in January 1994 as Executive Vice President, Chief Operating Officer, and a member of the Board of Directors following AVD's acquisition of GemChem Inc., a national and international chemical distribution company he co-founded in 1991. From 1977 to 1982, Mr. Wintemute, worked for AMVAC Chemical Corporation ("AMVAC"), a wholly owned subsidiary of AVD, in a variety of sales, purchasing and production control capacities. As a Vice President and Director of R.W. Greeff & Co. from 1982 to 1991, Mr. Wintemute oversaw the national and international distribution of key AMVAC chemical products. Mr. Wintemute holds a Bachelors of Science in Economics from the University of California, San Diego.

zelder
Chat Pages: Latest  66  65  64  63  62  61  60  59  58  57  56  55  Older

Your Recent History

Delayed Upgrade Clock